HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Restrictive cardiomyopathy — Clinical Guidelines

Overview

Restrictive cardiomyopathy encompasses a group of disorders characterized by impaired ventricular filling due to stiffness, often leading to clinical features similar to heart failure but with preserved ejection fraction. This summary focuses on restrictive cardiomyopathy associated with restrictive dermopathy, a rare lethal neonatal condition primarily affecting skin and skeletal structures 3 4 5 6.

Diagnosis

Clinical Features: Prematurity, fixed facial expression, micrognathia, tense and erosive skin, joint contractures, respiratory insufficiency 3 4 5 6.

Histological Findings: Thin dermis with hypoplasia of appendages, abnormal collagen arrangement, and near absence of elastic fibers 3 5 6.

Genetic Testing: LMNA gene mutations or ZMPSTE24 gene insertions leading to lamin A defects 3 4.

Skin Biopsy: Useful but may fail prenatally due to timing of skin changes 5.

Management

Supportive Care: Focus on managing respiratory insufficiency, nutritional support, and pain management 2.

Genetic Counseling: Essential for families with consanguinity and recurrent cases 3 4.

No Specific Pharmacological Treatment: Limited evidence for targeted drug therapy; management is largely supportive 2 3 4 5 6.

Special Populations

Pediatrics: Infants with restrictive dermopathy typically present with severe neonatal complications including prematurity and multisystem involvement 2 3 4 5 6.

Comorbidities: Often includes respiratory failure and skin abnormalities requiring multidisciplinary care 2 3 4 5 6.

Key Recommendations

Genetic Testing for LMNA and ZMPSTE24 Mutations: Essential for confirming diagnosis in suspected cases (Evidence: Strong 3 4).

Multidisciplinary Approach: Incorporate neonatology, genetics, dermatology, and pulmonology for comprehensive care (Evidence: Moderate 2 3 4 5 6).

Supportive Respiratory Management: Prioritize interventions to support respiratory function in neonates (Evidence: Expert opinion 2).

References

1 Ker J. Endomyocardial fibrosis: an enigmatic cause for a giant left atrium. Tropical doctor 2009. link 2 Bosque E. Complex case study: nursing care of an infant with restrictive dermopathy. The Journal of perinatal & neonatal nursing 2009. link 3 Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, Geneviève D et al.. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Human molecular genetics 2004. link 4 Smitt JH, van Asperen CJ, Niessen CM, Beemer FA, van Essen AJ, Hulsmans RF et al.. Restrictive dermopathy. Report of 12 cases. Dutch Task Force on Genodermatology. Archives of dermatology 1998. link 5 Mau U, Kendziorra H, Kaiser P, Enders H. Restrictive dermopathy: report and review. American journal of medical genetics 1997. link1096-8628(19970808)71:2<179::aid-ajmg11>3.0.co;2-b) 6 Verloes A, Mulliez N, Gonzales M, Laloux F, Hermanns-Lê T, Piérard GE et al.. Restrictive dermopathy, a lethal form of arthrogryposis multiplex with skin and bone dysplasias: three new cases and review of the literature. American journal of medical genetics 1992. link

Restrictive cardiomyopathy